Purpose: This study evaluated the prognostic value of preoperative locoregional staging in patients with colon cancer and who underwent curative resection.
introduction
Colon cancer is one of the most common malignancies found in the Western world and it usually ranks high in incidence and mortality among all malignancies in those countries [1] . The pathological TNM (tumor-nodemetastasis) stage is the gold standard for predicting the prognosis of various solid cancers and it is the most reliable prognostic factor for patients with colon cancer after curative colectomy. Although the TNM classification is useful for staging patients and selecting specific treatment, it is insufficient as many patients at the same stage may have different clinical outcomes and different responses to adjuvant therapy. Several biologic markers have been suggested as prognostic indicators but nothing other than the pathological stage is used in practice because of the inconvenience or discordant results when using other prognostic indicators [2] [3] [4] .
The preoperative radiological stage has been suggested to be correlated with the prognosis of colon cancer [5] . Several authors have found that preoperative computed tomography (CT) can provide useful information in patients with colon cancer and most often this relates to the detection of liver metastases [6] [7] [8] [9] [10] [11] . However, no additional information is available concerning the prognostic significance of the radiological stage in patients with nonmetastatic colon cancer. Therefore, we conducted this study to evaluate the prognostic value of preoperative locoregional staging in patients with colon cancer and who underwent curative resection.
methods
The consecutive patients who underwent curative surgery for nonmetastatic colon cancer at our department between February 1999 and November 2007 were prospectively enrolled in the present study. All the patients had biopsy-proven colon adenocarcinoma. The patients with recurrent disease, metastatic disease, or rectal cancer were excluded from the study cohort. The patients who did not have CT images to review were also excluded. All CT findings were prospectively reported. Ultimately, 536 patients were included in the present analysis. This study was reviewed and approved by the appropriate institutional review board.
preoperative staging
The preoperative clinical evaluation included a physical examination, colonoscopy or double-contrast barium enema, abdominopelvic CT, chest CT or X-ray, a complete blood cell count, liver function tests, and assessing the serum carcinoembryonic antigen (CEA) level. We used CT scans and the 7th International Union Against Cancer (UICC) TNM staging system to assess the radiological stage. T stages were defined as follows: T1, tumor invasion of submucosa; T2, tumor invasion of muscularis propria; T3, tumor invasion through the muscularis propria into pericolorectal tissues; T4a, tumor penetration into the surface of the visceral peritoneum; and T4b, tumor invasion or adhesion into other organs or structures. N stages were defined as follows: N0, no regional lymph node metastases; N1, 1 to 3 regional lymph nodes; and N2, 4 or more regional lymph nodes.
All patients with suspected colon malignancy in colonoscopy were carried out with CT scanning and CT colonography. CT scans were obtained on a 4-channel multidetector CT (MDCT) (HiSpeed Advantage; GE Medical Systems, Milwaukee, WI), 16-channel MDCT (LightSpeed; GE Medical Systems), or 64-channel MDCT (LightSpeed VCT; GE Medical Systems) scanner [12] . Twenty-four hours before examination, each patient received standard bowel preparation. The patients were allowed only a clear liquid diet until after the preparation had been completed. To prepare for the colonoscopy and CT colonography, all patients ingested 4 l of a polyethylene glycol electrolyte solution, which was initiated at 6 pm on the day before the examination. Once the oral lavage solution had been administrated, each patient ingested 10 mg of bisacodyl, to reduce residual fecal material and retained fluid, at 10 pm on the day before the examination. The scanning procedures were carried out during a breath-hold. First, the colon was insufflated by gentle squeezing of the enema bag, using room air, until the patients stated they were full or until 2000 ml had been administered. The adequacy of the air insufflation was evaluated with a CT scout view, with more air being insufflated if required. After the scanning of CT scout view in the supine position had been completed, the contrast-enhanced images were acquired with the patients in the supine position. And then CT scanning images in the prone position were obtained. After the administration of several additional puffs of air, the rectal tube was removed to improve patient comfort and prevent a possible rectal lesion. Contrast-enhanced CT was carried out after i.v. injection of an iodinated contrast agent, iopromide (Ultravist 300; Schering, Berlin, Germany); 120 ml of contrast agent was administered at 3 ml/s. CT was carried out during the portal venous phase (start delay of 60 s) and delayed phase (start delay of 180 s). The scanning parameters were 120 kVp, 120-160 mAs, a 512 · 512 matrix, and a 2.5-mm reconstruction thickness with 1-mm reconstruction intervals. The average acquisition time was 15 s. The evaluation began with the 2D transverse CT images, followed by a 3D CT colonography. The CT colonography viewing was carried out both antegrade and retrograde, with the patient both supine and prone, to avoid blind areas.
We considered a lymph node to be positive if the longest diameter was >1.0 cm or if it was 0.7 to 1.0 cm in size and it showed strong enhancement, a round shape, central necrosis, or perinodal infiltration because all of which suggest metastasis. A specialist in gastrointestinal cancer imaging and who was blinded to the surgical pathological findings (YYJ) interpreted or reviewed all the CT images.
surgery and follow-up
All the patients underwent standard colectomy and regional lymphadenectomy according to the tumor location. Curative resection was defined as when no gross residual tumor remained in the surgical bed and the proximal and distal resection margins were pathologically negative for tumor invasion. The pathological staging was also determined by the final pathological features according to the 7th UICC TNM classification. The patients with stages II and III disease were recommended to receive postoperative 5-fluorouracil-based chemotherapy, and 384 (71.6%) of the 536 patients received it [13, 14] . The decision to administer postoperative adjuvant therapy was made after assessing the general health of the patients and with their acceptance of the therapy. The patients were followed at 3-month intervals for 2 years, at 6-month intervals for the next 3 years, and then annually thereafter. On a semiannual basis or when a suspicion of recurrence existed, follow-up examinations were conducted that included a clinical history, physical examination, serum CEA assay, chest X-ray and/or CT, abdominopelvic CT, colonoscopy, and positron emission tomography scanning, if available. Recurrence was determined by clinical and radiological examinations or using histological confirmation. The main pattern of recurrence was recorded as the first site of detectable failure during the follow-up period.
statistical analysis
Statistical evaluation was carried out using the statistical package SPSS for Windows (Version 14.0; SPSS Inc., Chicago, IL). Differences between the two groups were tested using a Student's t-test and the chi-squared test, where appropriate. Local recurrence-free survival, disease-free survival, and overall survival curves were calculated using the Kaplan-Meier method. Differences between curves were evaluated using the log-rank test. Variables with a statistical P value < 0.10 on a univariate analysis were entered into a Cox model multivariate analysis. A P value £ 0.05 was deemed to be statistically significant.
results
The analysis included 316 (59.0%) men, and their median age was 64 years (range: 22-92 years). There were 177 patients (33.0%) with ascending colon cancers, 80 (14.9%) with transverse colon cancers, 33 (6.2%) with descending colon cancers, and 246 (45.9%) with sigmoid colon cancers. The median preoperative serum CEA level was 3.2 (range: 0.1-286.0) ng/ml. Of the 536 patients, 410 patients (73.6%) underwent open resection and 126 (26.4%) underwent laparoscopic-assisted colectomy. The median number of resected lymph nodes was 15 (range: 1-85). Using the 7th UICC TNM staging system, 60, 225, and 251 patients had radiological stages I, II, and III cancers, respectively, and 51, 263, and 222 patients had pathological stages I, II, and III cancers, respectively. Table 1 shows the results of the radiological UICC T staging systems compared with the results of pathological examination. The overall accuracy was 79.1% with overstaging occurring in 9.9% of the patients and understaging occurring in 11.0%. Table 2 reveals the results of the N staging. The overall accuracy was 73.7% with overstaging occurring in 16.0% of the patients and understaging occurring in 10.3%.
The median follow-up period of this study was 58.4 months. The 5-year overall survival and disease-free survival rates of the patients with radiological T1, T2, T3, and T4 were 96%, 89%, 75%, and 79%, respectively, and 100%, 98%, 77%, and 68%, respectively (P = 0.028 and P = 0.002, respectively; Figure 1A and B). The 5-year overall survival and disease-free survival rates were 83%, 76%, and 54%, respectively, and 86%, 78%, and 53%, respectively, for the patients with radiological N0, N1, and N2 disease (P < 0.001 and P < 0.001, respectively; Figure 2A and B). Similar findings were also observed for both the radiological TNM staging system and pathological TNM staging system ( Figure 3 ). The 5-year overall survival and disease-free survival rates of the patients with radiological TNM stages I, II, and III were 90%, 81%, and 70%, respectively (P < 0.001; Figure 3A ), and 100%, 83%, and 71%, respectively (P < 0.001; Figure 3B ). The 5-year overall survival and disease-free survival rates of the patients with pathological TNM stages I, II, and III were 93%, 80%, and 70%, respectively (P = 0.001; Figure 3C ), and 100%, 84%, and 69%, respectively (P < 0.001; Figure 3D ).
On a univariate analysis, the factors associated with poorer overall survival were lymphovascular invasion, perineural invasion, the operative method, the number of retrieved lymph nodes, the preoperative serum CEA level, postoperative chemotherapy, the radiological T stage, and the radiological N stage (Table 3) . On the univariate analysis, the factors associated with poorer disease-free survival were tumor size, lymphovascular invasion, perineural invasion, the preoperative serum CEA level, postoperative chemotherapy, the radiological T stage, and the radiological N stage (Table 3) . On a multivariate analysis, lymphovascular invasion, perineural invasion, the number of retrieved lymph nodes, postoperative chemotherapy, the radiological T stage, and the radiological N stage were independent prognostic factors for overall survival (Table 4) . Lymphovascular invasion, perineural invasion, the radiological T stage, and the radiological N stage were independent prognostic factors for disease-free survival (Table 4) . Additionally, the pathological T and N stages were independent prognostic factors for both overall survival and disease-free survival (Table 5) .
discussion
The pathological stage is currently the most reliable prognostic factor for patients with colon cancer after they undergo curative colectomy. In the era of pre-or perioperative therapy for resectable colorectal cancer, the radiological stage before preoperative treatment has become more crucial for predicting the outcome and evaluating treatment efficacy. CT has the potential to visualize local tumor characteristics in addition to its role in detecting any distant metastatic disease. It has the advantage of being universally available and easily reproducible. Several investigators have found that a preoperative CT scan provides useful information for up to half of the patients and it definitely alters the clinical management in 20% of patients with colon cancer [7] [8] [9] . With the advances in CT technology and computing software, CT has also shown potential not only as a staging modality but also for predicting the prognosis of patients with colon cancer [5] . However, the preoperative setting is limited by the absence of pathological information at baseline because the pathological stage can be determined only after resection for tumor, and the preoperative treatment could alter the baseline pathological stage. Furthermore, some authors have suggested that the information obtained from CT examinations in patients with colon cancer is not enough to significantly alter the management of these patients, except in cases with wide metastatic spread [6] [7] [8] [9] [10] [11] .
In the present study of 536 colon cancer patients who had received curative resection, we demonstrated that the accuracy of the radiological staging using CT scans was not clearly satisfactory, and the radiological T or N classification was an independent predictor of both overall survival and disease-free survival. To date, most of the published series regarding the accuracy and clinical usefulness of preoperative CT staging have found that this is related to the detection of liver metastases [6] [7] [8] [9] [10] [11] . In our study, we excluded the patients with preoperatively detected distant metastases in order to evaluate whether preoperative CT staging could be useful for predicting survival for the majority of patients who do not have stage IV disease. This study, to the best of our knowledge, is the largest one to investigate the role of the radiological stage for predicting the long-term survival of patients with curatively resected colon cancer.
Our results showed an accuracy of 79.1% for detecting tumor infiltration using MDCT scanners, and these results are consistent with previous findings of 48%-81% for the T staging [15] [16] [17] [18] . Although the diversity of the definition of the depth of invasion ('serosal', 'extramural', or 'local invasion of tumor', etc) makes direct comparison between other studies and our own results difficult, we observed that MDCT scanners, which are able to collect 1-mm thick slices within a single breath hold and this permits 3D reconstruction, gave improved resolution and image quality in our series. A recent meta-analysis that focused on 19 series has shown that MDCT has the potential to make a considerable impact in improving the accuracy of staging of colon cancer with a specificity of 93% and a sensitivity of 86% for detecting tumor invasion and a specificity of 87% and a sensitivity of 70% for detecting lymph node metastasis [19] . They also stated that the results were clearly better in the studies that used a section thickness of £5 mm as they used spiral CT or MDCT. In addition, two series using CT colonography, like ours, have produced good results with correct T staging reported for 26 (78.7%) of 33 and 30 (81%) of 37 colorectal tumors [15, 16] . Several investigators suggested that with the current 16-or 64-channel machines, it is not only possible to view the reformatted images in 3D but 
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it is also possible to use these machines for CT colonography, and so these machines can be used as a diagnostic tool as well as a staging tool [20, 21] . We agree with this and we observed encouraging results of 79.1% accuracy for the T staging using MDCT scanners with CT colonography in our series.
The difficulties of predicting lymph node metastases using a CT scan are well known. That is, small-or normal-sized nodes may have microscopic tumor infiltration, whereas very large nodes may occasionally be reactive rather than malignant. There still remains the open question as to the original articles Annals of Oncology definition of metastatic lymph nodes. Although there are several criteria for nodal positivity, such as the lymph node size, shape, and echogenicity, the nodal size still has been deemed to be the most frequent and reliable criterion for defining nodal positivity. We considered a lymph node to be positive if the longest diameter was >1.0 cm or if it was 0.7-1.0 cm in size and it showed strong enhancement, a round shape, central necrosis, or perinodal infiltration and all of which suggests metastasis. In our series, we also obtained 73.7% accuracy for predicting the nodal status by one experienced radiologist and this figure is consistent with the previous findings of 60%-80% for the N staging [15] [16] [17] [18] . Better-defined criteria with proper validation for staging lymph nodes are essential for the future utility of this imaging modality.
This study is interesting because it highlights the heterogeneity of the actual clinical outcomes for different radiological stages. There is currently no other published study that has directly compared the preoperative CT staging of the primary tumor with the clinical outcome, except the study by Smith et al. [5] . Smith et al. [5] suggested that CT is a robust method for stratifying patients preoperatively, with accuracy similar to that of the histopathology for predicting the outcome. However, in their study, the T stage and nodal status were correctly predicted in only 60% and 62% of the cases, respectively. Moreover, they did not show whether or not CT-based T staging or N staging is the independent prognostic factor for survival using a multivariate Cox regression model. Clearly, to date, no imaging modality that evaluates gross morphology (such as CT) is as accurate as microscopic examination. The correlation between CT-based assessment and prognosis in our study may be partly due to the encouraging results of 79.1% accuracy for the T staging and 73.7% accuracy for the N staging using MDCT scanning with CT colonography. To the best of our knowledge, this is the first report that the CT-predicted radiological stage could be a strong independent predictor for the survival of colon cancer patients, although the CT stage may not exactly correlate with the pathological stage.
The present study had some limitations. First, although the current study is large-scale one, this retrospective analysis of the prospectively collected data had not proven that the radiological staging used as a stratification criterion will overcome the bias regarding the tumor burden in future clinical trials that will assess the value of preoperative treatment. In particular, the significant proportion of patients who are understaged with CT ( Figure 4A and B) , despite the use of a modern MDCT technique, is a matter of concern, as this may imply that many Contrast-enhanced CT image shows eccentric wall thickening (arrows) without infiltration of the pericolic fat plane, which corresponds to T1 disease. However, it was proven to be T3 on histopathology.
(B) Contrast-enhanced CT image shows concentric wall thickening with pericolic infiltration (arrows). An intact fat plane between the lesion and duodenal loop (arrowhead) was observed, suggesting a T3 cancer without invasion of the duodenum. It was, however, found to be T4 on histopathology, as the tumor had invaded into duodenum. patients with high risk will be undertreated. Second, the preoperative staging in the present study was based on CT alone, which may be not the best modality for staging the T classification. Furthermore, prospective studies with intensive preoperative staging using a CT scanner that has advanced CT technology and computing software are need to confirm and extend our findings. Although our findings are insufficient for drawing definite conclusions, they still have validity.
Our results have possible implications for clinical practice. By including the radiological stage as a stratification factor in future trials of preoperative therapy, we may minimize the potential bias of regarding the disease burden and so we may be able to better evaluate the true efficacy of preoperative treatment. Yet, it also has to be noted that the radiological stage is inaccurate as a surrogate of the pathological stage and that it may not have any relationship with the true efficacy of preoperative treatment. In conclusion, the preoperative radiological stage should be considered as an important prognostic factor, before the pathological stage is known, in the preoperative setting of colon cancer patients. We believe that it should be incorporated as a stratification factor in a future randomized clinical trial of preoperative therapy for colon cancer patients. 
